| Literature DB >> 31703294 |
Di Xiao1,2,3, Lan Guo1, Meijun Zhao1, Sheng Zhang1, Wenyan Li1, Wei-Hong Zhang2,4, Ciyong Lu1,3.
Abstract
Sleep disturbance and non-medical prescription opioid use (NMPOU) are currently growing public health concerns, and sex differences may result in differential exposure to frequency of NMPOU or sleep disturbance. This study aimed to explore the association between the frequency of lifetime or past-year NMPOU and sleep disturbance and to evaluate whether there was any sex difference in this association among Chinese adolescents. A cross-sectional study was performed in seven randomly selected Chinese provinces through the 2015 School-Based Chinese Adolescents Health Survey. A total of 159,640 adolescents were invited to participate and among them, 148,687 adolescents' questionnaires were completed and qualified for this study (response rate: 93.14%). All analyses were performed for boys and girls separately. There were significant sex differences in the prevalence of lifetime or past-year opioid misuse and sleep disturbance (p < 0.05). Among girls, frequent lifetime NMPOU (adjusted odds ratio [aOR] = 2.09, 95% CI = 1.80-2.44) and past-year NMPOU (aOR = 2.16, 95% CI = 1.68-2.77) were positively associated with sleep disturbance. Among boys, these associations were also statistically significant, while the magnitudes of associations between frequent lifetime NMPOU or past-year NMPOU and sleep disturbance were greater in girls than those in boys. There is a significant sex difference in the prevalence of lifetime or past-year NMPOU and sleep disturbance. Furthermore, exposure to more frequent lifetime or past-year NMPOU is associated with a greater risk of sleep disturbance, especially among girls. Taking into account the sex difference for lifetime or past-year NMPOU may help to decrease the risk of sleep disturbance.Entities:
Keywords: adolescents; non-medical prescription opioid use; sex differences; sleep disturbance
Mesh:
Substances:
Year: 2019 PMID: 31703294 PMCID: PMC6888280 DOI: 10.3390/ijerph16224339
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sex difference of the sample characteristics (n = 148,687).
| Variable | Total, No. (%) | Boys | Girls | |
|---|---|---|---|---|
|
| 148,687 | 71,442 (48.0) | 77,245 (52.0) | <0.001 |
|
| ||||
| 12 to 13 | 34,890 (23.5) | 16,844 (23.6) | 18,046 (23.4) | <0.001 |
| 14 to 15 | 51,225 (34.5) | 25,782 (36.1) | 25,443 (32.9) | |
| 16 to 18 | 62,572 (42.1) | 28,816 (40.3) | 33,756 (43.7) | |
|
| ||||
| 7th to 9th | 77,936 (52.4) | 39,717 (55.6) | 38,219 (49.5) | <0.001 |
| 10th to 12th | 70,751 (47.6) | 31,725 (44.4) | 39,026 (50.5) | |
|
| ||||
| Above average | 52,839 (35.7) | 24,364 (34.2) | 28,475 (37.0) | <0.001 |
| Average | 49,782 (33.6) | 21,172 (29.7) | 28,610 (37.2) | |
| Below average | 45,470 (30.7) | 25,651 (36.0) | 19,819 (25.8) | |
|
| ||||
| Good | 81,130 (54. 8) | 39,494 (55.5) | 41,636 (54.1) | <0.001 |
| Average | 61,886 (41.8) | 28,094 (39.5) | 33,792 (43.9) | |
| Poor | 5156 (3.5) | 3564 (5.0) | 1592 (2.1) | |
|
| ||||
| Good | 108,178 (73.0) | 52,656 (74.0) | 55,522 (72.1) | <0.001 |
| Average | 37,389 (25.2) | 16,873 (23.7) | 20,516 (26.6) | |
| Poor | 2655 (1.8) | 1664 (2.3) | 991 (1.3) | |
|
| ||||
| Below average | 23,238 (15.6) | 12,712 (17.8) | 10,526 (13.6) | <0.001 |
| Average | 68,591 (49.2) | 31,494 (44.1) | 37,097 (48.1) | |
| Above average | 56,676 (38.2) | 27,147 (38.0) | 29,529 (38.3) | |
|
| ||||
| No | 136,458 (91.8) | 63,204 (88.5) | 73,254 (94.8) | <0.001 |
| Yes | 12,229 (8.2) | 8238 (11.5) | 3991 (5.2) | |
|
| ||||
| No | 140,855 (94.7) | 64,708 (90.6) | 76,147 (98.6) | <0.001 |
| Yes | 7832 (5.3) | 6734 (9.4) | 1098 (1.4) | |
|
| ||||
| No | 125,120 (84.1) | 56,357 (78.9) | 68,763 (89.0) | <0.001 |
| Yes | 23,567 (15.9) | 15,085 (21.1) | 8482 (11.0) | |
|
| <0.001 | |||
| Abstainers | 139,321 (93.7) | 66,426 (93.0) | 72,895 (94.4) | |
| Experimenters | 6679 (4.5) | 3529 (4.9) | 3150 (4.1) | |
| Frequent users | 2687 (1.8) | 1487 (2.1) | 1200 (1.6) | |
|
| <0.001 | |||
| Abstainers | 144,447 (97.1) | 69,139 (96.8) | 75,308 (97.5) | |
| Experimenters | 3228 (2.2) | 1738 (2.4) | 1490 (1.9) | |
| Frequent users | 1012 (0.7) | 565 (0.8) | 447 (0.6) | |
|
| ||||
| No | 116,522 (78.4) | 56,694 (79.4) | 59,828 (77.5) | <0.001 |
| Yes | 32,165 (21.6) | 14,748 (20.6) | 17,417 (22.5) |
NMPOU, non-medical prescription opioid use; Number of missing data were listed in superscript; 1 Chi-square tests were used to test the association between the above-mentioned categories and sex.
Lifetime prevalence, crude odds ratios, and 95% CI of sleep disturbance among adolescents: stratified by sex.
| Variable | Sleep Disturbance | ||||
|---|---|---|---|---|---|
| Total | Boys | cOR (95%CI) | Girls | cOR (95%CI) | |
|
| |||||
| Abstainers | 29,153 (20.9) | 13,263 (20.0) | 1 | 15,890 (21.8) | 1 |
| Experimenters | 1972 (29.5) | 946 (26.8) | 1.49 (1.36–1.62) | 1026 (32.6) | 1.71 (1.57–1.87) |
| Frequent users | 1040 (38.7) | 539 (36.2) | 2.25 (2.00–2.54) | 501 (41.8) | 2.65 (2.31–3.03) |
|
| |||||
| Abstainers | 30,720 (21.3) | 14,033 (20.3) | 1 | 16,687 (22.2) | 1 |
| Experimenters | 1004 (31.1) | 484 (27.8) | 1.50 (1.33–1.70) | 520 (34.9) | 1.90 (1.67–2.16) |
| Frequent users | 441 (43.6) | 231 (40.9) | 2.74 (2.26–3.33) | 210 (47.0) | 2.99 (2.43–3.67) |
|
| |||||
| 12 to 13 | 3763 (10.8) | 1723 (10.2) | 1 | 2040 (11.3) | 1 |
| 14 to 15 | 9838 (19.2) | 4480 (17.4) | 1.81 (1.67–1.95) | 5358 (21.1) | 2.11 (1.94–2.29) |
| 16 to 18 | 18,564 (29.7) | 8545 (29.7) | 3.64 (3.35–3.95) | 10,019 (29.7) | 3.33 (3.07–3.61) |
|
| |||||
| 7th to 9th | 11,097 (14.2) | 5328 (13.4) | 1 | 5769 (15.1) | 1 |
| 10th to 12th | 21,068 (30.0) | 9420 (30.0) | 2.70 (2.54–2.88) | 11,648 (30.0) | 2.37 (2.21–2.53) |
|
| |||||
| Above average | 9762 (18.5) | 4350 (17.9) | 1 | 5412 (19.0) | 1 |
| Average | 10,616 (21.3) | 4194 (19.8) | 1.15 (1.08–1.22) | 6422 (22.4) | 1.23 (1.17–1.29) |
| Below average | 11,704 (25.7) | 6177 (24.1) | 1.48 (1.40–1.56) | 5527 (27.9) | 1.66 (1.57–1.74) |
|
| |||||
| Good | 13,605 (16.8) | 6332 (16.0) | 0.58 (0.55–0.61) | 7273 (17.5) | 0.55 (0.53–0.58) |
| Average | 16,327 (26.4) | 6956 (24.8) | 1 | 9371 (27.7) | 1 |
| Poor | 2145 (41.6) | 1411 (39.6) | 1.92 (1.75–2.10) | 734 (46.1) | 2.21 (1.95–2.50) |
|
| |||||
| Good | 20,772 (19.2) | 9668 (18.4) | 0.61 (0.58–0.64) | 11,104 (20.0) | 0.62 (0.59–0.65) |
| Average | 10,288 (27.5) | 4413 (26.2) | 1 | 5875 (28.6) | 1 |
| Poor | 1018 (38.3) | 621(37.3) | 1.64 (1.45–1.86) | 397 (40.1) | 1.69 (1.44–1.98) |
|
| |||||
| Below average | 2918 (12.6) | 1701 (13.4) | 1 | 1217 (11.6) | 1 |
| Average | 10,706 (15.6) | 4569 (14.5) | 0.62 (0.55–0.69) | 6137 (16.5) | 0.72 (0.62–0.83) |
| Above average | 18,517 (32.7) | 8472 (31.2) | 1.35 (1.23–1.48) | 10,045(34.0) | 1.89 (1.66–2.15) |
|
| |||||
| No | 27,600 (20.2) | 11,858 (18.8) | 1 | 15,742 (21.5) | 1 |
| Yes | 4565 (37.3) | 2890 (35.1) | 2.38 (2.24–2.54) | 1675 (42.0) | 2.64 (2.44–2.85) |
|
| |||||
| No | 29,223 (20.7) | 12,328 (19.1) | 1 | 16,895 (22.2) | 1 |
| Yes | 2942 (37.6) | 2420 (35.9) | 2.39 (2.23–2.57) | 522 (47.5) | 3.43 (2.95–4.00) |
|
| |||||
| No | 24,382 (19.5) | 10,107 (17.9) | 1 | 14,275 (20.8) | 1 |
| Yes | 7783 (33.0) | 4641 (30.8) | 2.01 (1.90–2.12) | 3142 (37.0) | 2.26 (2.13–2.40) |
NMPOU, non-medical prescription opioid use; cOR, crude odds ratio; 95% CI, 95% confidence interval.
Adjusted odds ratios and 95%CI for measuring the association between opioids use and sleep disturbance stratified by sex.
| Variable | Sleep Disturbance | |
|---|---|---|
| Boys, aOR (95%CI) 1 | Girls, aOR (95%CI) 1 | |
|
| ||
| Abstainers | 1 | 1 |
| Experimenters | 1.25 (1.14–1.38) | 1.44 (1.31–1.59) |
| Frequent users | 1.80 (1.57–2.05) | 2.09 (1.80–2.44) |
|
| ||
| Abstainers | 1 | 1 |
| Experimenters | 1.24 (1.09–1.42) | 1.53 (1.33–1.76) |
| Frequent users | 2.07 (1.66–2.58) | 2.16 (1.68–2.77) |
NMPOU, non-medical prescription opioid use; aOR, adjusted odds ratio; 95% CI, 95% confidence interval. 1 Adjusted for age (years), grade, academic achievement, teacher–classmate, classmate relations, academic pressure, bullying experience, cigarette smoking, current drinking.
Figure 1Adjusted OR and 95%CI for measuring the association of lifetime or past-year NMPOU with sleep disturbance stratified by sex.* p < 0.05.